Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the cost of lost productivity in the workplace due to allergic rhinitis compared to other selected medical conditions from an employer perspective. SETTING AND PARTICIPANTS: A total of 8267 US employees at 47 employer locations who volunteered to participate in health/wellness screenings. MEASUREMENTS: The Work Productivity Short Inventory was used to assess the impact of a predefined group of health conditions on workplace productivity for the previous 12 months. Both absenteeism and presenteeism (lost productivity while at work) were recorded. Costs were calculated using a standard hourly wage. RESULTS: Allergic rhinitis was the most prevalent of the selected conditions; 55% of employees reported experiencing allergic rhinitis symptoms for an average of 52.5 days, were absent 3.6 days per year due to the condition, and were unproductive 2.3 h per workday when experiencing symptoms. The mean total productivity (absenteeism + presenteeism) losses per employee per year were 593 US dollars for allergic rhinitis, 518 US dollars for high stress, 277 US dollars for migraine, 273 US dollars for depression, 269 US dollars for arthritis/rheumatism, 248 US dollars for anxiety disorder, 181 US dollars for respiratory infections, 105 US dollars for hypertension or high blood pressure, 95 US dollars for diabetes, 85 US dollars for asthma, and 40 US dollars for coronary heart disease. The mean total productivity loss per employee per year due to caregiving was 102 US dollars for pediatric respiratory infections, 85 US dollars for pediatric allergies, 49 US dollars for Alzheimer's disease, and 42 US dollars for otitis media/earache. CONCLUSIONS: Allergies are major contributors to the total cost of health-related absenteeism and presenteeism. Payers and employers need to consider this when determining health benefits for employees.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a survey of over 8000 U.S. employees at 47 employer locations, 55% reported AR symptoms for an average of 52.5 days per year. They reported missing 3.6 days of work per year because of AR and reported being unproductive 2.3 hours per workday when symptomatic. The mean total productivity losses (absenteeism and presenteeism) for AR were calculated at $593 per employee per year.769”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [769]
Citations
Cites
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Current estimates from the National Health Interview Survey.
Ss, J. (1981) · PubMed · Cited by 1,866
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242
The Work Limitations Questionnaire
Lerner, D., Amick, B. C., Rogers, W. H., Malspeis, S., Bungay, K., & Cynn, D. (2001) · Medical Care · doi:10.1097/00005650-200101000-00009 · Cited by 971
Stanford Presenteeism Scale: Health Status and Employee Productivity
Koopman, C., Pelletier, K. R., Murray, J. F., Sharda, C. E., Berger, M. L., Turpin, R. S., Hackleman, P., Gibson, P., Holmes, D. M., & Bendel, T. (2002) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200201000-00004 · Cited by 821
Dykewicz, M. S., Fineman, S., Skoner, D. P., Nicklas, R., Lee, R., Blessing-Moore, J., Li, J. T., Bernstein, I. L., Berger, W., Spector, S., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63155-9 · Cited by 652
The effects of chronic medical conditions on work loss and work cutback
Kessler, R. C., Greenberg, P. E., Mickelson, K. D., Meneades, L. M., & Wang, P. S. (2001) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200103000-00009 · Cited by 468
Kessler, R. C., Barber, C., Birnbaum, H. G., Frank, R. G., Greenberg, P. E., Rose, R. M., Simon, G. E., & Wang, P. (1999) · Health Affairs · doi:10.1377/hlthaff.18.5.163 · Cited by 388
Labor and Health Status in Economic Evaluation of Health Care: The Health and Labor Questionnaire
Van Roijen, L., Essink-bot, M.-L., Koopmanschap, M. A., Bonsel, G., & Rutten, F. F. H. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009764 · Cited by 303
Corren, J., Adinoff, A. D., Buchmeier, A. D., & Irvin, C. G. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90079-h · Cited by 290
Research works printed but not linked: 5
- Adams PF, 1995, Vital Health Stat, 193, 1
- Collins JG, 1989, Adv Data, 168, 1
- Murray JJ, 2002, Allergy Asthma Proc, 23, 391
- Ross RN, 1996, Am J Managed Care, 2, 285
- Endicott J, 1997, Psychopharmacol Bull, 33, 13
Cited by
Items 101–200 of 290
Pollen allergy and health behavior: patients trivializing their disease
Muzalyova, A., Brunner, J. O., Traidl‐Hoffmann, C., & Damialis, A. (2019) · Aerobiologia · doi:10.1007/s10453-019-09563-5 · Cited by 35
Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study
Vieira, R. J., Azevedo, L. F., Pereira, A. M., Nogueira-Leite, D., Gonçalves, F. R., Larenas‐Linnemann, D. E., Cruz, Á. A., Gemicioğlu, B., Samolinski, B. K., Vecillas, L. D. L., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.07.026 · Cited by 35
Meltzer, E. O., Stahlman, J. E., Leflein, J. G., Meltzer, S. M., Lim, J., Dalal, A. A., Prillaman, B. A., & Philpot, E. E. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.02.005 · Cited by 37
Lam, S. C., Yeung, C. C. Y., Chan, J. H. M., Lam, D. W. C., Lam, A. H. Y., Annesi‐Maesano, I., & Bousquet, J. J. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000477727 · Cited by 32
Memory and multitasking performance during acute allergic inflammation in seasonal allergic rhinitis
Trikojat, K., Buske-Kirschbaum, A., Plessow, F., Schmitt, J. M., & Fischer, R. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12893 · Cited by 31
Participation restrictions at work indicate participation restrictions in other domains of life
Muschalla, B., Vilain, M., Lawall, C., Lewerenz, M., & Linden, M. (2011) · Psychology Health & Medicine · doi:10.1080/13548506.2011.592840 · Cited by 28
“There are many studies on health-related occupational disability, such as reduced work productivity or absence from work (Kühn et al., 2002; Haslam, Atkinson, Brown, & Haslam, 2005; Lamb et al., 2006).”
BackgroundThe Role of Allergen Immunotherapy in the Management of Allergic Rhinitis
Cox, L. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4253 · Cited by 28
Weber, R. W. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.09.001 · Cited by 33
Isolating the species element in grass pollen allergy: A review
Frisk, C. A., Adams‐Groom, B., & Smith, M. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163661 · Cited by 28
Factors related to presenteeism among employees of the private sector
Mandıracıoğlu, A., Bolukbas, O., Demirel, M., & Gumeli, F. (2015) · International Journal of Occupational Safety and Ergonomics · doi:10.1080/10803548.2015.1017967 · Cited by 27
“It is stated that presenteeism is the reason for 18–61% of total health cost.[9] It is estimated that in Australia the cost of presenteeism in 2010 was around 34.”
BackgroundOremus, M., & Aguilar, S. C. (2010) · PharmacoEconomics · doi:10.2165/11539450-000000000-00000 · Cited by 31
“The remaining articles were from the US, 17 of which reported costs based on national-level data.([11,27,28,30,34,35,37,40,42-44,50,52,53,56,57,59]) Twenty-seven articles described the costs associated with providing care for patients diagnosed with AD,([13,14,16-20,25,26,28-31,33,34,36,37,42,43,45,46,52-54,56,58,59])…”
BackgroundMethodInfluentialLipworth, B. J., Newton, J., Ram, B., Small, I. R., & Schwarze, J. (2017) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-016-0001-y · Cited by 32
Demoly, P. M., Matucci, A., Rossi, O., & Vidal, C. (2020) · Clinical and Translational Allergy · doi:10.1186/s13601-020-00331-0 · Cited by 28
Brożek, J., Borowiack, E., Sadowska, E., Nowak, A. J., Sousa‐Pinto, B., Vieira, R. J., Bognanni, A., Yepes-Núñez, J. J., Zhang, Y., Zuberbier, T., et al. (2024) · Allergy · doi:10.1111/all.16100 · Cited by 28
Fujino, Y., Shazuki, S., Izumi, H., Uehara, M., Muramatsu, K., Kubo, T., Oyama, I., & Matsuda, S. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000788 · Cited by 26
Beer, L. T. D. (2014) · SA Journal of Human Resource Management · doi:10.4102/sajhrm.v12i1.640 · Cited by 32
“3 hours per day are spent being unproductive due to symptoms (Lamb et al., 2006).”
BackgroundInfluentialMeijster, T., van Duuren-Stuurman, B., Heederik, D. J. J., Houba, R., KONINGSVELD, E. A. P., Warren, N. D., & Tielemans, E. (2011) · Occupational and Environmental Medicine · doi:10.1136/oem.2011.064709 · Cited by 26
Mazurek, J. M., & Henneberger, P. K. (2017) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-017-1217-z · Cited by 26
“3 h of productivity loss per workday resulting in $593 of total productivity losses per employee per year (the mean total productivity losses per employee for other conditions ranged from $518 for high stress to $40 for coronary heart disease) (Lamb et al. 2006).”
InfluentialApproach to Patients with Allergic Rhinitis
Cox, L. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.09.001 · Cited by 32
Dev, S., Acharyya, R. N., Akter, S., Bari, M. A. A., Asma, K., Hossain, H., Sarkar, K. K., Biswas, N. N., & Das, A. K. (2021) · Clinical Phytoscience · doi:10.1186/s40816-021-00301-4 · Cited by 28
Huang, J.-W., Bai, Y.-Y., Wang, D.-S., He, W., Zhang, J.-L., Tu, H.-X., Wang, J., Zhang, Y., Wu, Q.-Z., Xu, S.-L., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134226 · Cited by 24
Mechanism and clinical evidence of immunotherapy in allergic rhinitis
Carli, M., Capezzali, E., Tonon, S., & Frossi, B. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1217388 · Cited by 24
“In fact, AR is the most prevalent cause of absenteeism and/or presenteeism at workplace, and the global loss of job productivity caused by AR is noticeably greater than that caused by other common pathologies including depression, infections, diabetes (5).”
BackgroundHankin, C. S., Cox, L., Lang, D. M., Bronstone, A. B., Wang, Z., Lepore, M. S., & Buck, P. O. (2012) · Allergy and Asthma Proceedings · doi:10.2500/aap.2012.33.3565 · Cited by 24
“The costs of lost workplace productivity due to AR exceed those of other common illnesses, including arthritis, asthma, diabetes, hypertension, migraine, and coronary heart disease.(8) Based on their superior effectiveness compared with other classes of AR medications, guidelines recommend intranasal corticosteroids (…”
BackgroundPatient adherence to allergic rhinitis treatment: results from patient surveys.
Valovirta, E. J., & Ryan, D. P. (2008) · PubMed Central · Cited by 27
Work Ability and Labor Supply after Kidney Transplantation
Sangalli, V., Dukes, J. L., Doppalapudi, S. B., Costa, G., & Neri, L. (2014) · American Journal of Nephrology · doi:10.1159/000365155 · Cited by 21
Choi, S. Y., & Park, K.-S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7896081 · Cited by 24
Impact of Vitamin D Deficiency on the Productivity of a Health Care Workforce
Plotnikoff, G. A., Finch, M. D., & Dusek, J. A. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318240df1e · Cited by 21
Yamamoto, S. S., Loerbroks, A., & Terris, D. D. (2009) · Preventive Medicine · doi:10.1016/j.ypmed.2009.02.019 · Cited by 20
Brake, D. L., Yaman, R. N., Camargo, A., Marks, L. A., Maddux, J. T., Ochkur, S. I., & Rank, M. A. (2023) · Allergy and Asthma Proceedings · doi:10.2500/aap.2023.44.230022 · Cited by 19
Virani, F. R., Wilson, M., Beliveau, A. M., Gill, A. S., Strong, E. B., & Steele, T. O. (2021) · Ear Nose & Throat Journal · doi:10.1177/01455613211018576 · Cited by 20
“This is further compounded by the loss of productivity, with nearly a quarter of all lost productivity in the United States could be attributed to this condition.(5) For patients who have 1 UC Davis Health, Department of Otolaryngology—Head and Neck Surgery, Sacramento, CA, USA 2 Division of Biostatistics, Department…”
Molzon, E. S., Hullmann, S. E., Eddington, A. R., & Mullins, L. L. (2011) · Journal of Asthma & Allergy Educators · doi:10.1177/2150129711416501 · Cited by 19
The Association of Health Risks with Absenteeism and Presenteeism
Oh, S., Jung, K. T., & Park, J. Y. (2007) · Korean Journal of Occupational and Environmental Medicine · doi:10.35371/kjoem.2007.19.4.304 · Cited by 19
Effects of nonsedative antihistamines on productivity of patients with pruritic skin diseases
Murota, H., Kitaba, S., Tani, M., Wataya‐Kaneda, M., & Katayama, I. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02262.x · Cited by 19
“The symptoms associated with allergic diseases are recognized to exert a negative social and economic impact on patients as a result of impairments in work productivity (1, 2).”
BackgroundIlyina, N. I., Edin, A., Astafieva, N. G., As, L., Sidorenko, I. V., Ukhanova, O. P., & Khanova, F. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000494507 · Cited by 20
Zhu, R., Wang, J., Wu, Y., Yang, Y., Huang, N., Yang, Y., Zhang, R., Ma, D., Yang, L., & Demoly, P. M. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.05.028 · Cited by 19
The rhinitis control assessment test: implications for the present and future
Nathan, R. A. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000020 · Cited by 20
“made it the most costly of the 15 conditions examined [22].”
BackgroundCauwenberge, P. V., Hoecke, H. V., Kardos, P., Price, D. B., & Waserman, S. (2008) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2008.00042 · Cited by 19
“It shows that AR is associated with lost productivity, work absenteeism and ‘presenteeism’ (being present at work, but not fully functioning), similar to AR sufferers in the general population.(5-9) Over one-quarter of PCPs with AR reported losing an average of six hours of work a week during a typical week of AR symp…”
BackgroundBilastine and quality of life.
Jauregui, I., Bartra, J., del Cuvillo, A., Davila, I. J., Ferrer, M., Montoro, J., Mullol, J., Sastre, J., & Valero, A. (2011) · PubMed · Cited by 17
Meltzer, E. O., Andrews, C. P., Journeay, G. E., Lim, J., Prillaman, B. A., Garris, C. P., & Philpot, E. E. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2010.02.010 · Cited by 17
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis
Gonzalez‐Estrada, A., Reddy, K., Dimov, V., & Eidelman, F. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1346085 · Cited by 19
“health-related absenteeism and presenteeism [4].”
Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy
Cox, L. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1886079 · Cited by 16
“AR symptom severity was the most consistent disease-related factor impacting work productivity, In a survey of US employees, the total annual cost of lost productivity attributable to AR was significantly higher than the cost for any other condition assessed including diabetes and coronary heart disease [45] In Europe…”
BackgroundPettit, J. W., Grover, K. E., & Lewinsohn, P. M. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 19
NASAL-Geom, a free upper respiratory tract 3D model reconstruction software
Cercos-Pita, J. L., Cal, I. R., Duque, D., & de Moreta, G. S. (2017) · Computer Physics Communications · doi:10.1016/j.cpc.2017.10.008 · Cited by 15
Sickness Absence Among Female Employees With Migraine and Co-Existing Conditions
Mäki, K., Vahtera, J., Virtanen, M., Elovainio, M. J., Pentti, J., Keltikangas‐Järvinen, L., & Mika Kivimaki, B. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01649.x · Cited by 15
Malińska, M. (2013) · Medycyna Pracy · doi:10.13075/mp.5893.2013.0037 · Cited by 15
Cost-effectiveness of allergen immunotherapy
Rodríguez-Otero, N., Ramírez-Mateo, E., Plana, N., Heffler, E. M., & Antolín‐Amérigo, D. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001028 · Cited by 14
Rezagholi, M., & Bantekas, A. (2015) · Occupational Medicine & Health Affairs · doi:10.4172/2329-6879.1000225 · Cited by 14
“Despite studies attempting to identify and assess productivity loss due to sickness absenteeism and/or presenteeism [6-8,14,22,24,26,27], the applied models are undeveloped.”
BackgroundMethodEsterhuizen, N., Berman, D. M., Neumann, F. H., Ajikah, L., Quick, L. J., Hilmer, E., van Aardt, A. C., John, J., Garland, R. M., Hill, T., et al. (2023) · Clinical and Translational Allergy · doi:10.1002/clt2.12304 · Cited by 14
“In subtropical Durban located in the Indian Ocean Coastal Belt biome, 6 the daily average grass concentration seldom exceeded 30/ m 3 ; however, grasses did increase in January.”
Background100 Years of Immunotherapy: The Monaco Charter
Canonica, G. W., Baena‐Cagnani, C. E., Compalati, E., Bohle, B., Bonini, S., Bousquet, J. J., Cox, L., Fink-Wagner, A., Díaz, S. N. G., Jacobsen, L., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000343883 · Cited by 14
United Airway Disease Among Crop Farmers
Akpinar‐Elci, M., Pasquale, D. K., Abrokwah, M., Nguyen, M. T., & Elci, Ö. C. (2016) · Journal of Agromedicine · doi:10.1080/1059924x.2016.1179239 · Cited by 16
Allergenic pollen seasons and regional pollen calendars for Norway
Frisk, C. A., Brobakk, T. E., & Ramfjord, H. (2024) · Aerobiologia · doi:10.1007/s10453-023-09806-6 · Cited by 13
“Additionally, the effects on the individual contribute to an impact on a societal level due to the number of sufferers affected, causing measurable decline on societal work performance and economic productivity (Lamb et al., 2006; Zuberbier et al., 2014).”
Klimek, L., Bousquet, J. J., & Price, D. B. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1122755 · Cited by 14
“[26] AR also carries a high socioeconomic cost, mainly driven by absenteeism and productivity loss.[27,28] For the EU, avoidable indirect costs per patient insufficiently treated for allergy range between €55 and €151 billion per annum due to absenteeism and presenteeism, which equates to €2405 per untreated patient p…”
BackgroundARIA masterclass 2018: From guidelines to real-life implementation
Hellings, P. W., Seys, S., Mariën, G., Agache, I. O., Canonica, G. W., Gevaert, P., Haahtela, T., Klimek, L., Mullol, J., Pfaar, O., et al. (2019) · Rhinology Journal · doi:10.4193/rhin19.011 · Cited by 14
Bürgler, A., Glick, S., Hartmann, K., & Eeftens, M. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.689248 · Cited by 13
Pournik, O., Ghalichi, L., Yazdi, A. R. T., Tabatabaee, S. M., Ghaffari, M., & Vingård, E. (2012) · PubMed · Cited by 13
Impact of Medication Adherence on Work Productivity in Hypertension
Wagner, S., Lau, H., Frech‐Tamas, F., & Gupta, S. (2012) · Cited by 13
Mucci, T., Govindaraj, S., & Tversky, J. (2011) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20287 · Cited by 12
Aye, C. C., Toda, M., Morohoshi, K., & Ono, S. J. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.02.002 · Cited by 12
Goodman, M. J., Jhaveri, M., Saverno, K. R., Meyer, K. L., & Nightengale, B. S. (2008) · Europe PMC (PubMed Central) · Cited by 18
Richter, A.-K., Klimek, L., Merk, H. F., Mülleneisen, N. K., Renz, H. E., Wehrmann, W., Werfel, T., Hamelmann, E. H., Siebert, U., Sroczynski, G., et al. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-018-0970-6 · Cited by 13
Ansari, A. M., Farzampour, S., Sadr, A., Shekarchi, B., & Majidzadeh‐A, K. (2016) · Life Sciences · doi:10.1016/j.lfs.2015.12.055 · Cited by 12
Songnuy, T., Scholand, S. J., & Panprayoon, S. (2020) · Journal of Environmental and Public Health · doi:10.1155/2020/1692930 · Cited by 12
Sifuentes, L. Y., Fankem, S. L. M., Reynolds, K. A., Tamimi, A. H., Gerba, C. P., & Koenig, D. W. (2016) · Food and Environmental Virology · doi:10.1007/s12560-016-9256-2 · Cited by 11
“Even if an employee is not absent as a result of viral infection, the increased cost of significantly reduced productivity can equal or exceed those of absenteeism attributed to illness (Lamb et al. 2006).”
BackgroundImpacts of Allergic Rhinitis in Social Communication, Quality of Life and Behaviours of the Patients
Muluk, N. B. (2015) · Allergy Disorders & Therapy · doi:10.24966/adt-749x/100002 · Cited by 12
Diamine oxidase enzyme: a novel biomarker in respiratory allergy
Refaat, M. M., Abdel-Rehim, A. S. M., Elmahdi, A. R., Mohamed, N. A., & Ghonaim, S. S. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22426 · Cited by 12
Meltzer, E. O., Ratner, P. H., & McGraw, T. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.10.022 · Cited by 13
Self-citationKlimek, L., Chaker, A. M., & Mösges, R. (2017) · HNO · doi:10.1007/s00106-017-0410-4 · Cited by 11
Mapping naso-ocular symptom scores to EQ-5D-5L utility values in Japanese cedar pollinosis
Kumanomidou, H., Kanai, K., Oka, A., Haruna, T., Hirata, Y., Makihara, S., Higaki, T., Akamatsu, M., Okamoto, Y., Ikeda, S., et al. (2021) · Allergology International · doi:10.1016/j.alit.2021.11.002 · Cited by 10
Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol
Tully, P. J., Wittert, G., Turnbull, D. A., Beltrame, J. F., Horowitz, J. D., Cosh, S., & Baumeister, H. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0026-2 · Cited by 12
“Background Panic disorder is among the most prevalent mental health conditions in the community [1] and primary healthcare practice [2], collectively signifying a major public health burden in terms of economic costs [3,4], quality-adjusted”
BackgroundCosts of second-generation antihistamines in the treatment of allergic rhinitis: US perspective
Hay, J. W., & Kaliner, M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902875992 · Cited by 10
Japanese Cedar Pollinosis Impact on Work Productivity, Quality of Life, and Symptoms 2008 vs. 2009
Minami, Y., 塩崎, 由., Kato, C., Ito, M., Takeuchi, N., Koyanagi, M., & Ogino, S. (2010) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi.49.481 · Cited by 15
Scadding, G. K., Price, D. B., El‐Shanawany, T., Ahmed, S. K., Ray, J., Sargur, R. B., & Kumar, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014777 · Cited by 10
Determining factors of patient compliance in allergic rhinitis
Köberlein–Neu, J., Kothe, A. C., Sieber, J., & Mösges, R. (2013) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap0264.31.2.2013 · Cited by 10
Presenteeism and absenteeism before and after single-level lumbar spine surgery
Fontana, M. A., Islam, W., Richardson, M. A., Medina, C. K., Kohilakis, E. C., Qureshi, S. A., & MacLean, C. H. (2021) · The Spine Journal · doi:10.1016/j.spinee.2021.10.017 · Cited by 9
Sinha, S. D., Perapogu, S., Chary, S., Ramesh, S., Bakshi, J. B., Singh, A. P., Ahmed, A. K., Reddy, B. M., Panapakam, M., Talluri, L., et al. (2023) · Journal of Asthma · doi:10.1080/02770903.2023.2209175 · Cited by 9
“It is known to affect the patient’s social life as a result of disrupted nighttime sleep and inducing daytime drowsiness (2), resulting in a negative impact on work performance (3).”
Escaping the trap of allergic rhinitis
Rossi, O., Massaro, I., Caminati, M., Quecchia, C., Fassio, F., Heffler, E. M., & Canonica, G. W. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0023-y · Cited by 10
“Ironically, AR accounts for the greatest socioeconomic burden worldwide, higher than that induced by asthma, diabetes and heart disease [4].”
BackgroundDevillier, P., Brüning, H., & Bergmann, K. (2019) · Allergy · doi:10.1111/all.13925 · Cited by 9
Li, L., Liu, H., Wang, Y., Han, X., Ge, T., & Pan, L. (2020) · Indoor Air · doi:10.1111/ina.12694 · Cited by 10
Asthma-related productivity losses in Alberta, Canada
Thành, N. X. (2009) · Journal of Asthma and Allergy · doi:10.2147/jaa.s5072 · Cited by 9
“This is signifi cant but still lower than in the Lamb and colleagues study, 15 where the presenteeism accounted for 68%.”
Matsuura, R., Kawamura, A., Ota, R., Fukushima, T., Fujimoto, K., Kozaki, M., Yamashiro, M., Somei, J., Matsumoto, Y., & Aida, Y. (2023) · Toxics · doi:10.3390/toxics11080718 · Cited by 8
“For instance, they contribute to the highest financial burden in the USA, with an estimated loss of productivity of USD 593 per employee annually [3].”
BackgroundMedications for Allergic Rhinitis: An Opportunity for Quality Improvement?
Roditi, R. E., Ishman, S. L., Lee, S. J., Lin, S. Y., & Shin, J. J. (2016) · Otolaryngology · doi:10.1177/0194599816666064 · Cited by 8
“9 million per annum.(3) In fact, some economic analyses suggest that AR accounts for greater loss of productivity than any other illness.”
BackgroundPresenteeism and Absenteeism Before and After Total Hip and Knee Arthroplasty
Fontana, M. A., Islam, W., Richardson, M. A., Medina, C. K., McLawhorn, A. S., & MacLean, C. H. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.11.024 · Cited by 9
Müller, M., Igarashi, A., Hashiguchi, K., Kappel, M., Paolini, F., Yoshisue, H., Funakubo, M., Sharma, H., & Okano, M. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2033051 · Cited by 9
Prevalence trends and risk factors for allergic rhinoconjunctivitis, asthma and eczema in the UK
Diwakar, L., Subramanian, A., Shah, D., Subramaniam, S., Pelly, V. S., Greenfield, S., Moore, D. M., & Nirantharakumar, K. (2025) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-025-00975-2 · Cited by 8
“ARC has been associated with depression [5] shown to affect academic performance [6] reduce work place productivity [7] and exert a considerable financial burden on society [8].”
Thangavel, P., Kim, K. Y., Park, D., & Lee, Y. (2023) · Toxics · doi:10.3390/toxics11020113 · Cited by 7
“The methodology for evaluating indirect costs in cost-of-illness research studies is organically based on various assumptions about human and productivity values; it is crucial to compare research with similar assumptions and methodologies [83].”
Fritszching, B., Porsbjerg, C. M., Buchs, S., Larsen, J. R., Freemantle, N., & Contoli, M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1136942 · Cited by 7
“Upon entry into the workplace, allergic conditions can contribute to lost productivity, with subsequent socio-economic consequences (29, 30).”
BackgroundThe cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis
Sullivan, P. W., Navaratnam, P., Lorber, R. R., & Shekar, T. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003750381 · Cited by 7
Atiim, G. A., Elliott, S. J., & Clarke, A. E. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.03.031 · Cited by 8
“Several studies (Minaker et al., 2014; Peniamina et al., 2014, Lamb et al., 2006) also observe that the burden of food allergy care extends beyond financial costs to other indirect effects such as difficulty obtaining allergenic foods, increased time use, reduced work productivity through…”
BackgroundEvaluating the Effect of Recurrent Respiratory Papillomatosis on Work Productivity
Chung, T. K., Hu, A. C., Sardesaı, M. G., Wilcox, H., Jiang, L., & Meyer, T. K. (2021) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894211040900 · Cited by 7
Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray
Fromer, L. M., Ortiz, G., & Dowdee, A. M. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181865f99 · Cited by 7
“School attendance also suffers as a result.(16,17) Intranasal corticosteroids (INS) are recommended as first-line therapy for AR because of their demonstrated efficacy in reducing AR symptoms and favorable safety profile compared with systemic corticosteroids.”
BackgroundHamada, S., Kobayashi, Y., Sakamoto, D., Shimamura, A., Kuroda, K., Kawachi, R., Kanda, A., Asako, M., Gotoh, M., Okubo, K., et al. (2021) · Auris Nasus Larynx · doi:10.1016/j.anl.2021.01.003 · Cited by 8
Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire
Crawford, B., Stanford, Wong, Dalal, & Bayliss (2011) · Patient Related Outcome Measures · doi:10.2147/prom.s19371 · Cited by 7
Dickson, V. V. (2013) · The Open Public Health Journal · doi:10.2174/1874944501306010031 · Cited by 10
Saverno, K. R., Seal, B. S., Goodman, M. J., & Meyer, K. L. (2009) · Europe PMC (PubMed Central) · Cited by 9
Driving under the influence of allergies: the effect of seasonal pollen on traffic fatalities
Danagoulian, S., & Deza, M. (2024) · Journal of Health Economics · doi:10.1016/j.jhealeco.2024.102945 · Cited by 7
Immunology of the Upper Airway and Pathophysiology and Treatment of Allergic Rhinitis
Baroody, F. M., & Naclerio, R. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05283-2.00041-0 · Cited by 9
Wang, E., Diaz, A., Zhang, D., Dimitroyannis, R. C., Kim, D., Caballero, N., Pinto, J. M., & Roxbury, C. R. (2023) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.1192 · Cited by 6
“10,11 There is unexplained variation in the burden of rhinologic disease on an individual level.”
BackgroundUse of specific immunotherapy – a survey of 15 164 employed persons in Germany
Weberschock, T. B., Schaefer, I., Heigel, H., Valesky, E. M., Augustin, M., & Schmitt, J. M. (2014) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12298 · Cited by 6
Occupational rhinitis revisited: Emphasis on the risk factors in Saudi industry
Ballal, S. G. (2016) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/1658-631x.188254 · Cited by 6
“Productivity losses per year per affected person due to absenteeism and presenteeism combined were nearly 600 US dollars.[34]”
BackgroundA review of the pharmacoeconomics of eletriptan for the acute treatment of migraine
Bhambri, R., Mardekian, J., Liu, L., Schweizer, E. E., & Ramos, É. (2015) · International Journal of General Medicine · doi:10.2147/ijgm.s73673 · Cited by 6
“The overall economic burden of productivity losses associated with migraine in the USA exceeds that of chronic conditions of heart disease, diabetes, asthma, and depression.(13) The indirect costs of migraine, such as lost days from work and reduced productivity, are hugely uncertain but are considered to exceed direc…”
Metadata
- Authors
- Lamb, C. E., Ratner, P. H., Johnson, C. E., Ambegaonkar, A. J., Joshi, A. V., Day, D., Sampson, N., & Eng, B.
- Affiliations
- PCA Occupational Medicine, Salem, VA, USA
- Sylvana Research (US)
- ExxonMobil (United States) (US)
- Pfizer (United States) (US)
- Novo Nordisk Inc., Princeton, NJ, USA
- Corresponding author
- Joshi, Ashish V.
- ORCID
- Joshi, Ashish V.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2006-05-19
- Volume
- 22
- Issue
- 6
- Pages
- 1203-1210
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2098204210
- Cited by
- 288
- References
- 29
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 14 · 2023: 19 · 2022: 14 · 2021: 15 · 2020: 13 · 2019: 15 · 2018: 14 · 2017: 22 · 2016: 21 · 2015: 20 · 2014: 15 · 2013: 10 · 2012: 17
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- West Virginia University
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Workplace Health and Well-being
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- allergic rhinitis, workplace productivity loss, absenteeism, presenteeism, employer costs, caregiving costs, employee health benefits, migraine, depression, asthma, respiratory infections
- MeSH terms
- Costs and Cost Analysis, Humans, Respiratory Hypersensitivity, Rhinitis, United States, Prevalence, Occupational Health, Workplace
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.